| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 1,437 | 861 | +66.9% |
| EBITDA | 242 | 156 | +55.3% |
| EBITDA margin | 16.8% | 18.1% | −1.2 pts |
| Profit before tax | 162 | 145 | +11.6% |
| Net profit | 119 | 128 | −7.0% |
| EPS | ₹3.74 | ₹20.10 | −81.4% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 14,742 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 115 | 115 | 102 | 157 | 107 | ||
| 3,186 | 3,186 | 185 | 324 | 293 | ||
| 17,814 | — | — | — | — | ||
| 4,537 | 3,961 | 2,709 | 2,328 | 2,255 | ||
| — | +46.2% | +16.4% | +3.2% | — | ||
| 596 | 510 | 380 | 308 | 337 | ||
| 13.1% | 12.9% | 14.0% | 13.2% | 15.0% | ||
| 403 | 363 | 351 | 284 | 312 | ||
| 188 | 197 | 347 | 267 | 310 | ||
| 4.1% | 5.0% | 12.8% | 11.5% | 13.8% | ||
| ₹5.92 | ₹6.20 | ₹10.91 | ₹8.39 | ₹9.76 | ||
| — | −43.2% | +30.0% | −14.0% | — | ||
| — | 226 | 380 | 246 | 91.7 | ||
| — | −102 | −66.3 | −28.5 | −45.0 | ||
| 125 | 125 | 314 | 218 | 46.8 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 14,742.5 | |
| - Cash, Equiv & ST Investments | 107.0 | 156.9 | 102.4 | 114.8 | 114.8 | |
| + Total Debt | 292.5 | 324.0 | 185.0 | 3,186.4 | 3,186.4 | |
| Enterprise Value | — | — | — | — | 17,814.1 | |
| Revenue | 2,254.8 | 2,327.8 | 2,708.9 | 3,961.0 | 4,537.1 | |
| Growth %, YoY | — | +3.2 | +16.4 | +46.2 | — | |
| EBITDA | 337.2 | 308.2 | 379.7 | 509.7 | 595.8 | |
| Margin % | 14.95 | 13.24 | 14.02 | 12.87 | 13.13 | |
| EBIT | 312.1 | 284.4 | 351.3 | 363.0 | 402.8 | |
| Net Income | 310.4 | 266.9 | 346.9 | 197.2 | 188.2 | |
| Margin % | 13.76 | 11.47 | 12.81 | 4.98 | 4.15 | |
| EPS, Adj (current shares) | 9.76 | 8.39 | 10.91 | 6.20 | 5.92 | |
| Growth %, YoY | — | -14.0 | +30.0 | -43.2 | — | |
| Cash from Operations | 91.7 | 246.4 | 380.0 | 226.4 | — | |
| Capital Expenditures | -45.0 | -28.5 | -66.3 | -101.7 | — | |
| Free Cash Flow | 46.8 | 217.9 | 313.7 | 124.7 | 124.7 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Zydus Wellness (NSE: ZYDUSWELL) had a market capitalisation of ₹15,248 crore at the 29 October 2026 close (₹479.50 a share), a PE ratio of 81.0 on the last four quarters' profit and a price-to-book ratio of 2.62. In FY26 its consolidated net profit was ₹197 crore on revenue of ₹3,961 crore; in Q1 FY27 (April–June 2026) it was ₹119 crore, down 7.0% year on year. Its debt-to-equity ratio was 0.55 on 31 March 2026. Promoters held 69.64% of the shares on 30 September 2026.
Zydus Wellness' PE ratio is 81.0 at the 29 October 2026 close (₹479.50 a share): a market capitalisation of ₹15,248 crore divided by consolidated net profit of ₹188 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹197 crore) it is 77.3. These four quarters include net exceptional items of −₹40.8 crore (one-off charges reported separately), so the ratio on recurring profit would differ.
Zydus Wellness' price-to-book (PB) ratio is 2.62 at the 29 October 2026 close: a market capitalisation of ₹15,248 crore divided by shareholders' equity (book value) of ₹5,826 crore on 31 March 2026. That is a book value of ₹183.21 per share against a share price of ₹479.50.
In FY26, Zydus Wellness' return on equity (ROE) was 3.4% and its return on capital employed (ROCE) was 4.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 6.3% and ROCE 6.3%.
Zydus Wellness' market capitalisation was ₹15,248 crore at the 29 October 2026 close: 31.8 crore shares at ₹479.50 each.
No. Zydus Wellness had borrowings of ₹3,186 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.55. Its cash and current investments were ₹115 crore, so its net debt was ₹3,071 crore.
In 2026, Zydus Wellness has declared one dividend: ₹1.20 with record date 17 July 2026.
Zydus Wellness' debt-to-equity ratio was 0.55 on 31 March 2026: borrowings of ₹3,186 crore against total equity of ₹5,826 crore. A year earlier, on 31 March 2025, it was 0.03.
Zydus Wellness' net worth — shareholders' equity in its consolidated balance sheet — was ₹5,826 crore on 31 March 2026, up 2.7% from ₹5,672 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹15,248 crore at the 29 October 2026 close.
Zydus Wellness' book value per share was ₹183.21 on 31 March 2026: shareholders' equity of ₹5,826 crore divided by the 31.8 crore shares in issue. The share price at the 29 October 2026 close was ₹479.50.
Zydus Wellness' basic earnings per share (EPS) were ₹6.20 in FY26.
Promoters held 69.64% of Zydus Wellness on 30 September 2026, unchanged from the previous quarter and up 0.01 percentage points from 69.63% a year earlier, according to the shareholding pattern filed with NSE.
Zydus Wellness will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
On 30 September 2026, Zydus Wellness' shares were held by promoters 69.64%, foreign portfolio investors (FII/FPI) 3.56%, domestic institutions (DII) 19.39% (including mutual funds at 18.72%) and retail and other non-institutional investors 7.41%. Over the year, FII holding was up 0.13 percentage points from 3.43% and DII holding was up 0.63 percentage points from 18.76%.
At the 29 October 2026 closing prices, on FY26 net profit, Zydus Wellness' PE ratio is 77.3, the highest of the four: Dabur India 34.6, Emami 20.9 and Tata Consumer 65.5, a peer average of 40.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Zydus Wellness earned net profit of ₹197 crore on revenue of ₹3,961 crore, against ₹1,895 crore on ₹13,193 crore for Dabur India. Zydus Wellness' operating margin was 9.2% (Dabur India 15.0%) and its return on equity 3.4% (Dabur India 17.1%). At the 29 October 2026 close, Zydus Wellness' market capitalisation was ₹15,248 crore against ₹65,638 crore for Dabur India, and its PE ratio on FY26 profit 77.3 against 34.6.
In FY26, Zydus Wellness generated ₹226 crore of cash from operations and spent ₹102 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹125 crore. In FY25 it was ₹314 crore.
Zydus Wellness' latest results are for Q1 FY27 (April–June 2026), filed on 4 August 2026: consolidated net profit ₹119 crore, down 7.0% from ₹128 crore in Q1 FY26; revenue from operations ₹1,437 crore, up 66.9% year on year.
In FY26 (April 2025–March 2026), Zydus Wellness' consolidated net profit was ₹197 crore, down 43.2% from ₹347 crore in FY25, on revenue from operations of ₹3,961 crore (up 46.2%). Over three years, from FY23, net profit was down 36.5%.
On FY26 consolidated figures, against Dabur India, Emami and Tata Consumer: Zydus Wellness' operating margin of 9.2% is the lowest of the four (Dabur India 15.0%, Emami 20.8%, Tata Consumer 10.7%; peer average 15.5%); its return on equity of 3.4% is the lowest of the four (Dabur India 17.1%, Emami 27.6%, Tata Consumer 7.4%; peer average 17.3%); its revenue growth over three years of 20.7% a year is the highest of the four (Dabur India 4.6% a year, Emami 3.5% a year, Tata Consumer 13.8% a year; peer average 7.3% a year).
From Zydus Wellness' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.